B7H3 expression and significance in idiopathic pulmonary fibrosis. Issue 3 (22nd December 2021)

• Record Type: Journal Article
• Authors: Fang, Chuling; Rinke, Andrew E; Wang, Jing; Flaherty, Kevin R; Phan, Sem H; Liu, Tianju
• Is Part Of: Journal of pathology. Volume 256:Issue 3(2022)
• Page Start: 310
• Page End: 320
• Publication Date: 2021-12-22
• Subjects: B7H3 -- bone marrow -- MDSC -- cell migration -- inflammation -- IPF; Pathology -- Periodicals; 616.07
• DOI: 10.1002/path.5838
• Languages: English
• ISSNs: 0022-3417

Abstract

Abstract: The clinical significance of B7H3 (CD276) and its cleavage product soluble B7H3 (sB7H3) in idiopathic pulmonary fibrosis (IPF) is unknown. Mounting evidence suggests the potential utility of peripheral blood myeloid cell enumeration to predict disease outcome and indicate active lung disease. Here we hypothesized that sB7H3 is involved in regulation of circulating myeloid cells in pulmonary fibrosis. In support of this possibility, both plasma sB7H3 and B7H3 + cells were elevated in IPF patient blood samples, which correlated negatively with lung function. To analyze its function, the effects of sB7H3 on naïve or bleomycin‐treated mice were examined. The results revealed that sB7H3 injection induced an influx of myeloid‐derived suppressor cells (MDSCs) and Ccl2 expression in lung tissue of naïve mice, accompanied by enhanced overall inflammation. Additionally, sB7H3 caused accumulation of MDSCs in bone marrow with increased expression of inflammatory cytokines. Notably, in vitro assays revealed chemotaxis of MDSCs to sB7H3, which was dependent on TLT‐2 (TREML2), a putative receptor for sB7H3. Thus, increased circulating sB7H3 and/or B7H3 + cells in IPF patient blood samples correlated with lung function decline and potential immunosuppressive status. The correlation of sB7H3 with deterioration of lung function might be due to its ability to enhance inflammation and recruitment of MDSCs into the lung and their expansion in the bone marrow, and thus potentially contribute to IPF exacerbation. © 2021 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.